Evonik stock at EUR 20.87, down 0.62% before Xetra
Published on 11/13/2026 at 07:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat matters for Evonik stock
- Third-quarter 2026 reporting was scheduled for November 3.
- The next quarterly report is scheduled for March 4, 2027.
- Evonik's investor calendar lists first-quarter 2027 reporting for May 4.
Evonik stock traded at EUR 20.87 on Lang & Schwarz at 07:46 CET on Friday, November 13, 0.62 percent below the Xetra close of Thursday, November 12 at EUR 21.00.
Reporting dates remain in focus
Evonik's investor calendar lists third-quarter 2026 reporting on November 3 and sets the next quarterly report for March 4, 2027. First-quarter 2027 results are scheduled for May 4. The dates are listed in the company's investor relations calendar.
The premarket indication leaves the stock below the latest Xetra close before the Frankfurt session. Investors will focus on the outlook for specialty chemicals demand, portfolio actions and the company's progress toward its scheduled reporting dates.
German equities are tracked against the DAX.
Further updates and analysis are available on more news and analyses on Evonik stock.
